Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Human Pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0046-8177(93)90055-L
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated ras alleles in human carcinoma of the prostate are rare.

  1991cited by this paper
• Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.

  1991cited by this paper
• Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

  1990cited by this paper
• Growth factors and oncogenes in prostate cancer.

  1990cited by this paper
• Allelic loss of chromosomes 16q and 10q in human prostate cancer.

  1990cited by this paper
• Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

  1990cited by this paper
• TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop.

  1990cited by this paper
• Rat prostate cancer cells contain functional receptors for transforming growth factor-beta.

  1990cited by this paper
• The prostate: An increasing medical problem

  1990cited by this paper
• ras gene mutations in human prostate cancer.

  1990cited by this paper
• Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

  1990cited by this paper
• Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.

  1990cited by this paper
• The int‐2 gene product acts as an epithelial growth factor in transgenic mice.

  1990cited by this paper
• Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta.

  1990cited by this paper
• Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia

  1990cited by this paper
• Cancer statistics, 1990

  1990cited by this paper
• Frequency and pattern of karyotypic abnormalities in human prostate cancer.

  1990cited by this paper
• Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

  1989cited by this paper
• Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes

  1989cited by this paper
• Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread

  1988cited by this paper
• Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers

  1988cited by this paper
• Activated ki‐ras oncogene in human prostatic adenocarcinoma

  1987cited by this paper
• Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

  1986cited by this paper
• Bi‐functional action of transforming growth factor‐β on DNA synthesis in early passage human fetal fibroblasts

  1986cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper
• Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

  1986cited by this paper
• Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia.

  1986cited by this paper
• Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alpha

  1986cited by this paper
• Origin and evolution of benign prostatic enlargement.

  1978cited by this paper
• Cancer of the prostate among men with benign prostatic hyperplasia.

  1974cited by this paper
• Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study.

  1974cited by this paper

• A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer

  2021cites this paper
• Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3.

  2018cites this paper
• Importance de la co-dérégulation des voies RAS/MAPK et PI3K/AKT/mTOR dans la transformation épithéliale prostatique. Approche in vivo à l'aide d'un modèle dans les glandes accessoires de la Drosophile

  2018cites this paper
• Identification of Novel targeting peptides for PC3 cells by the screening of a phage display peptide library

  2015cites this paper
• Identification of targeting peptides to human prostate cancer cells (LNCAP) using phage display peptide libraries

  2015cites this paper
• Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer

  2015cites this paper
• Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up

  2014cites this paper
• A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential

  2014cites this paper
• Emerging Roles of Human Prostatic Acid Phosphatase

  2013cites this paper
• Blood-Based Tumor Markers for Prostate Cancer

  2013cites this paper
• PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway

  2013cites this paper
• Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions

  2011cites this paper
• Tumor markers in prostate cancer I: Blood-based markers

  2011cites this paper
• The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression

  2011cites this paper
• Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.

  2010cites this paper
• Circulating cytokine levels in prostate cancer patients undergoing radiation therapy: influence of neoadjuvant total androgen suppression.

  2009cites this paper
• Development of Novel Assays for Measuring Different Molecular Forms of Prostate Specific Antigen

  2009cites this paper
• New circulating biomarkers for prostate cancer

  2008cites this paper
• Key Roles of TGF-β and Smad3 in Prostate Cancer

  2008cites this paper
• Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers

  2008cites this paper
• Cytokines as potential tumour markers.

  2008cites this paper
• New blood‐based biomarkers for the diagnosis, staging and prognosis of prostate cancer

  2008cites this paper
• Reactive Stroma and Evolution of Tumors: Integration of Transforming Growth Factor-β, Connective Tissue Growth Factor, and Fibroblast Growth Factor-2 Activities

  2008cites this paper
• Targeted Downregulation of TGF-β2 with AP 12009 in Tumor Therapy

  2008cites this paper
• Soluble TGF-β Type III Receptor Suppresses Malignant Progression of Human Cancer Cells

  2008cites this paper
• Transforming Growth Factor-β and the Immune Response to Malignant Disease

  2007cites this paper
• Advances in Brief Dietary Fenretinide , a Synthetic Retinoid , Decreases the Tumor Incidence and the Tumor Mass of ras + myc-induced Carcinomas in the Mouse Prostate Reconstitution Model System 1

  2007cites this paper
• Transforming Growth Factor-B and the Immune Response toMalignant Disease

  2007cites this paper
• Review Prostate Cancer Progression Implications of Histopathology

  2007cites this paper
• Id-1 promotes TGF-beta1-induced cell motility through HSP27 activation and disassembly of adherens junction in prostate epithelial cells.

  2007cites this paper
• System Carcinomas in the Mouse Prostate Reconstitution Model-induced ras + myc Tumor Incidence and the Tumor Mass of Dietary Fenretinide , a Synthetic Retinoid , Decreases the Updated

  2007cites this paper
• Blood biomarkers for prostate cancer detection and prognosis.

  2007cites this paper
• Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.

  2006cites this paper
• TGF-β Receptor Kinase Inhibitors for the Treatment of Cancer

  2006cites this paper
• Targeted tumor therapy with the TGF-β2 antisense compound AP 12009

  2006cites this paper
• Runx2 expression is associated with pathologic new bone formation around radicular cysts: an immunohistochemical demonstration.

  2006cites this paper
• Molecular markers of prostate cancer.

  2006cites this paper
• Seminar article Molecular markers of prostate cancer

  2006cites this paper
• Matrix metalloproteinases -21 and -26 in keratinocytes and in keratinocyte-derived cancers

  2005cites this paper
• Thalidomide and its use in renal and prostate cancer

  2005cites this paper
• Role of Tumour Microenvironment in Chemoresistance

  2005cites this paper
• Androgen and Glucocorticoid Receptors in the Stroma and Epithelium of Prostatic Hyperplasia and Carcinoma 1

  2005cites this paper
• Effect of TGF-β on paracellular transport in the rat submandibular gland acini

  2004cites this paper
• Angiogenesis in Prostate Cancer: Biology and Therapeutic Opportunities

  2004cites this paper
• Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.

  2004cites this paper
• Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.

  2004cites this paper
• Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study

  2004cites this paper
• Paracrine communication between malignant and non-malignant prostate epithelial cells in culture alters growth rate, matrix protease secretion and in vitro invasion

  2004cites this paper
• Leptin induces cell migration and the expression of growth factors in human prostate cancer cells.

  2004cites this paper
• Expression of transforming growth factor-β receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment

  2004cites this paper
• Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF‐β1

  2004cites this paper
• Reduced Infiltration of Class A Scavenger Receptor Positive Antigen-Presenting Cells Is Associated with Prostate Cancer Progression

  2004cites this paper
• Decreased Pigment Epithelium-Derived Factor Is Associated with Metastatic Phenotype in Human and Rat Prostate Tumors

  2004cites this paper
• Survivin expression is associated with features of biologically aggressive prostate carcinoma

  2004cites this paper
• Differential expression of transforming growth factor-β1 and β3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer

  2004cites this paper
• A Gain of Function TGFB 1 Polymorphism May Be Associated With Late Stage Prostate Cancer

  2004influential citation
• Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression

  2004cites this paper
• Regulationof Rat Prostate StromalCell

  2004cites this paper
• Angiogenesis and prostate cancer tumor growth

  2004influential citation
• A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.

  2004cites this paper
• Molecular biology of prostate cancer

  2004cites this paper
• Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts

  2003cites this paper
• Molecular therapeutics in prostate cancer.

  2003cites this paper
• Neuroepithelial interactions in prostate cancer are enhanced in the presence ofprostatic stroma.

  2003cites this paper
• Matrix Metalloproteinase-21 Is Expressed Epithelially During Development and in Cancer and Is Up-Regulated by Transforming Growth Factor-β1 in Keratinocytes

  2003cites this paper
• Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.

  2003cites this paper
• Reversal of Tumor-induced Immunosuppression by TGF-β Inhibitors

  2003cites this paper
• Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines.

  2002cites this paper
• Suppressive effects of transforming growth factor-beta1 produced by hepatocellular carcinoma cell lines on interferon-gamma production by peripheral blood mononuclear cells.

  2002cites this paper
• Signal Transduction Pathways Modulate Androgen Receptor Transcriptional Activity

  2002cites this paper
• Growth factors and their receptors in prostate cancer

  2002cites this paper
• Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage.

  2002cites this paper
• Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine

  2002cites this paper
• Molekulare Grundlagen des Prostatakarzinoms

  2002cites this paper
• Preoperative P lasma L evels o f T ransforming G rowth F actor Beta 1 (TGF- b 1 ) S trongly P redict P rogression i n P atients Undergoing R adical P rostatectomy

  2001cites this paper
• PhageDisplay Selectionof PeptidesThatAffect ProstateCarcinomaCellsAttachment and Invasion

  2001cites this paper
• Role of transforming growth factor‐β1 in prostate cancer

  2001cites this paper
• Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer

  2001cites this paper
• Collagen Matrix in Development and Progression of Experimentally Induced Respiratory Neoplasms in the Hamster

  2001cites this paper
• Transforming growth factor β in the human prostate: Its role in stromal–epithelial interactions in non‐cancerous cell culture

  2001cites this paper
• Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion

  2001cites this paper
• Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.

  2001cites this paper
• Thrombospondin‐1, vascular endothelial growth factor and fibroblast growth factor‐2 are key functional regulators of angiogenesis in the prostate

  2001cites this paper
• New concepts in the pathology of prostatic epithelial carcinogenesis.

  2001cites this paper
• Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.

  2000cites this paper
• Eicosanoid Regulation of Angiogenesis in Human Prostate Carcinoma and Its Therapeutic Implications

  2000cites this paper
• The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.

  2000cites this paper
• Differential expression of nuclear retinoid receptors in normal and malignant prostates.

  2000cites this paper
• Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease

  2000cites this paper
• Differential E xpression o f N uclear R etinoid R eceptors i n Normal a nd M alignant P rostates

  2000cites this paper
• Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

  2000cites this paper
• Beyond prostate specific antigen--markers for prostate cancer for the 21st Century.

  2000cites this paper
• Growth factors and epithelial-stromal interactions in prostate cancer development.

  2000cites this paper
• TGF‐β isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis

  2000cites this paper
• Cell lineage characteristics of human prostatic stromal cells cultured in vitro

  2000cites this paper
• Endothelium‐derived factors as paracrine mediators of prostate cancer progression

  2000cites this paper
• Prostate Cancer Mitogen-activated Protein Kinase Signaling Pathway in Human Effect by Oncogenic HaRas-induced Activation of the 1 β Mitogenic Conversion of Transforming Growth Factor-Updated

  2000cites this paper
• α5 Integrin distribution and TGFβ1 gene expression in supraglottic carcinoma: Their role in neoplastic local invasion and metastasis

  2000cites this paper
• Transforming Growth Factor-ß1 and Prostate Cancer

  2000cites this paper
• Chapter 7 Angiogenesis in prostate cancer

  1999cites this paper